Mitochondrial autophagosomes as a mechanism of drug resistance in breast carcinoma. (4th March 2018)

• Record Type: Journal Article
• Authors: Abunimer, Ayman N.; Mohammed, Heba; Cook, Katherine L.; Soto-Pantoja, David R.; Campos, Maria Mercedes; Abu-Asab, Mones S.
• Is Part Of: Ultrastructural pathology. Volume 42:Number 2(2018)
• Page Start: 170
• Page End: 180
• Publication Date: 2018-03-04
• Subjects: Breast carcinoma -- drug resistance -- mitochondria -- mitoautophagosomes -- MKT-077 -- multidrug resistance -- P-glycoprotein -- P-gp efflux pump; Pathology, Cellular -- Periodicals; Ultrastructure (Biology) -- Periodicals; Diagnosis, Electron microscopic -- Periodicals; Microscopy, Electron; Pathology; 616.07582
• DOI: 10.1080/01913123.2017.1419328
• Languages: English
• ISSNs: 0191-3123

Abstract

ABSTRACT: We have previously described the process by which mitochondria donate their membranes for the formation of autophagosomes, and in this study we show that the same process could be involved in drug sequestration and exocytosis resulting in multidrug-resistant cancerous cells. We examine the implications of mitochondrial vesicle formation of mitoautophagosomes (MAPS) in response to the cytotoxic drug MKT-077, which targets mortalin, in a drug-resistant breast carcinoma cell line overexpressing P-glycoprotein (P-gp). The breast cancer cell line MCF-7Adr is derived from MCF-7, but differs from its ancestral line in tolerance of MKT-077-induced mitochondrial toxicity. Our ultrastructural observations suggest that autophagy in the MCF-7Adr cells entails regional sequestration of MKT077 in multilamellar LC3-labeled MAPS, which then separate from their mitochondria, and fuse with or engulf each other. MAPS appeared to be migrating through the cytoplasm and fusing with the plasma membrane, thus carrying out exocytotic secretion. This mechanism, which seems ineffective in the ancestral cell line, provides a resistance mechanism for MKT-077 by enhancing the efflux process of the cells. After 8 hr of MKT-077 exposure, a fraction of the resistant cells appeared viable and contained larger number of smaller sized mitochondria. Mitoautophagosomes, therefore, provide a potentially novel model for multidrug resistance in cancerous cells and may contribute to the P-gp efflux process.